93 7456 (Glipizide and metformin hydrochloride 2.5 mg / 500 mg)

Pill imprint 93 7456 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 500 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 93 7456 (Glipizide and metformin hydrochloride 2.5 mg / 500 mg)

Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Front
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Back
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456
Glipizide and metformin hydrochloride
Imprint:
93
7456
Strength:
2.5 mg / 500 mg
Color:
White
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7456
Inactive Ingredients:
corn starch
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k30
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00555-0626 Barr Laboratories Inc
00591-3972 Watson Pharmaceuticals, Inc. (now Actavis, Inc)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)